|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
9 January 2023 |
|
Main ID: |
NCT03634215 |
|
Date of registration:
|
01/07/2018 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
|
|
Scientific title:
|
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma |
|
Date of first enrolment:
|
September 1, 2018 |
|
Target sample size:
|
357 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03634215 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Czechia
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- a patient with presumed severe trauma admitted to the participating centre
Exclusion Criteria:
- inflammatory disease
- malignant disease
- pregnancy
- receipt of any fibrinogen / coagulation factor XIII product before blood sampling
- patients on dabigatran
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Coagulation Disorder
|
|
Coagulation Defect; Acquired
|
|
Coagulation Factor Deficiency
|
|
Multiple Trauma
|
|
Intervention(s)
|
|
Diagnostic Test: fibrinogen plasma concentration, coagulation factor XIII activity
|
|
Primary Outcome(s)
|
|
coagulation factor XIII activity
[Time Frame: 1 day]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|